Table 1 Comparison of general data of the combined DTX group and the ADT group
Variable | DTX + ADT | ADT | P |
|---|---|---|---|
Number of patients | 63 | 90 | |
Age, years, median (range) | 69 (62–79) | 77.5 (66–91) | *0.001 |
Age, years, n (%) | |||
< 70 | 33 (52.4) | 15 (16.7) | |
≥ 70 | 30 (47.6) | 75 (83.3) | *0.001 |
PSA level, ng/ml, | 226.3 | 146.2 | |
Median (range) | (29.4–2892) | (35.3–2238) | *0.024 |
GS, n (%) | |||
6–7 | 27 (42.9) | 30 (33.3) | |
8–10 | 36 (57.1) | 60 (66.7) | 0.303 |
T stage, n (%) | |||
1–2 | 18 (28.6) | 27 (30) | |
3–4 | 45 (71.4) | 63 (70) | 0.991 |
N stage, n (%) | |||
N0 | 18 (28.6) | 21 (23.3) | |
N1 | 45 (71.4) | 69 (76.7) | 0.587 |
M stage, n (%) | |||
M1a | 0 (0) | 0 (0) | |
M1b | 51 (80.9) | 72 (80.0) | |
M1c | 12 (19.1) | 18 (20.0) | 0.951 |
ECOG, n (%) | |||
0 | 30 (60.0) | 12 (13.3) | |
1 | 24 (26.7) | 27 (30.0) | |
2 | 9 (13.3) | 24 (26.7) | |
3 | 0 (0) | 27 (30.0) | *0.001 |